Align manufactures 3D digital scanners and the Invisalign clear aligners used in orthodontics. And according to recent sales reports, its Invisalign cases for Q3 declined by 5%, compared to the 14% growth reported in Q2, and 23% increase in Q1.
Are you looking for fast-news, hot-tips and market analysis?
Sign-up for the Invezz newsletter, today.
Stifel’s Block said that also the decelerating growth trend was expected, the decline was a surprise. Nonetheless, the analyst retained a buy rating on ALGN shares with a price target of $750 per share, implying an upside potential of more than 25% on Wednesday’s closing price.
Is Align’s growth still realistic?
From an investment perspective, Align Technology shares trade at a step P/E ratio of 71.50, making the stock less attractive to growth investors. However, analysts expect its earnings per share to skyrocket by 305% this year, before rising at an average annual rate of about 31.83% over the next five years.
Therefore, growth investors could find the stock exciting. However, given the company’s declining sales trend for the Invisalign cases, the current growth projections may be overstated
Therefore, it may be best to monitor performance for the next few quarters before betting on ALGN’s growth prospects.
Technically, Align Technology shares seem to be trading within sharply descending channel formation in the intraday chart. As a result, the stock has plummeted to oversold conditions, creating an opportunity for a rebound.
Therefore investors could target short-term rebound profits at about $625.72, or higher at $655.33. On the other hand, $571.33 and $543.10 are crucial support zones.
ALGN seems poised for a rebound
In summary, although Align Technology’s long-term growth story may be put on hold until its sales growth spike again, Wednesday’s sharp decline creates an opportunity to bounce back.
Therefore, investors could buy the stock short-term ahead of a potential rebound.
Where to buy right now
To invest simply and easily, users need a low-fee broker with a track record of reliability. The following brokers are highly rated, recognised worldwide, and safe to use:
- R Balki’s next starring Dulquer Salmaan, Sunny Deol, Pooja Bhatt, Shreya Dhanwanthary titled Chup; Akshay Kumar unveils motion poster : Bollywood News – Bollywood Hungama
- DRS to make debut in upcoming men’s T20 World Cup | Cricket News – Times of India
- Jim Harbaugh says Nebraska victory ‘was a Clint Eastwood win’
- Bengal eyes revival of tourism this Durga Puja amid pandemic
- iraq: Iraqis vote for new parliament amid tight security – Times of India
- Shah Rukh Khan is feeling ‘broken, helpless’; has stopped ‘eating and sleeping’